Advertisement

Bleeding from Gynecologic Malignancies

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Clarke M.A.
        • Long B.J.
        • Del Mar Morillo A.
        • et al.
        Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis.
        JAMA Intern Med. 2018; 178: 1210-1222
        • Eleje G.U.
        • Eke A.C.
        • Igberase G.O.
        • et al.
        Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.
        Cochrane Database Syst Rev. 2019; 3: Cd011000
        • Lurain J.R.
        Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
        Am J Obstet Gynecol. 2010; 203: 531-539
        • Pereira J.
        • Phan T.
        Management of bleeding in patients with advanced cancer.
        Oncologist. 2004; 9: 561-570
        • Luisada A.A.
        The functional murmur: the laying to rest of a ghost.
        Dis Chest. 1955; 27: 579-581
        • Mozos I.
        Mechanisms linking red blood cell disorders and cardiovascular diseases.
        Biomed Res Int. 2015; 2015: 682054
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • et al.
        Fourth universal definition of myocardial infarction (2018).
        J Am Coll Cardiol. 2018; 72: 2231-2264
        • Holcomb J.B.
        • Tilley B.C.
        • Baraniuk S.
        • et al.
        Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.
        JAMA. 2015; 313: 471-482
        • Knopfelmacher A.M.
        • Martinez F.
        Massive transfusion protocols (MTPs) in cancer patients.
        in: Nates J.L. Price K.J. Oncologic critical care. Springer International Publishing, Cham (Switzerland)2020: 1205-1211
        • Roback J.D.
        • Caldwell S.
        • Carson J.
        • et al.
        Evidence-based practice guidelines for plasma transfusion.
        Transfusion. 2010; 50: 1227-1239
        • Holcomb J.B.
        • Wade C.E.
        • Michalek J.E.
        • et al.
        Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients.
        Ann Surg. 2008; 248: 447-458
        • Kaufman R.M.
        • Djulbegovic B.
        • Gernsheimer T.
        • et al.
        Platelet transfusion: a clinical practice guideline from the AABB.
        Ann Intern Med. 2015; 162: 205-213
        • Carson J.L.
        • Guyatt G.
        • Heddle N.M.
        • et al.
        Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage.
        JAMA. 2016; 316: 2025-2035
        • Zayed S.
        • Nguyen T.K.
        • Lin C.
        • et al.
        Red blood cell transfusion practices for patients with cervical cancer undergoing radiotherapy.
        JAMA Netw Open. 2021; 4: e213531
        • Monti M.
        • Castellani L.
        • Berlusconi A.
        • et al.
        Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit.
        J Pain Symptom Manage. 1996; 12: 18-22
        • Key N.S.
        • Khorana A.A.
        • Kuderer N.M.
        • et al.
        Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update.
        J Clin Oncol. 2020; 38: 496-520
        • Cuker A.
        • Burnett A.
        • Triller D.
        • et al.
        Reversal of direct oral anticoagulants: guidance from the Anticoagulation Forum.
        Am J Hematol. 2019; 94: 697-709
        • Thomas S.
        • Makris M.
        The reversal of anticoagulation in clinical practice.
        Clin Med (Lond). 2018; 18: 314-319
        • Kabi Fresenius
        Protamine Sulfate Injection, USP [prescribing information].
        (Available at:) (Accessed December 12, 2021)
        • ACOG committee opinion no
        557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women.
        Obstet Gynecol. 2013; 121: 891-896
        • James A.H.
        • Kouides P.A.
        • Abdul-Kadir R.
        • et al.
        Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel.
        Eur J Obstet Gynecol Reprod Biol. 2011; 158: 124-134
        • Shakur H.
        • Roberts I.
        • Bautista R.
        • et al.
        Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
        Lancet. 2010; 376: 23-32
        • Brenner A.
        • Afolabi A.
        • Ahmad S.M.
        • et al.
        Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
        Trials. 2019; 20: 467
        • Pharmacia & Upjohn Company L.L.C.
        Cyklokapron (tranexamic acid) [prescribing information].
        (Available at:) (Accessed December 12, 2021)
        • Gitlin N.
        • Serio K.M.
        Ischemic hepatitis: widening horizons.
        Am J Gastroenterol. 1992; 87: 831-836
        • Strassburg C.P.
        Gastrointestinal disorders of the critically ill. Shock liver.
        Best Pract Res Clin Gastroenterol. 2003; 17: 369-381
        • Practice Bulletin No. 149
        Endometrial cancer.
        Obstet Gynecol. 2015; 125: 1006-1026
        • Díaz-Montes T.P.
        • Zahurak M.L.
        • Giuntoli 2nd, R.L.
        • et al.
        Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality.
        Gynecol Oncol. 2006; 103: 1043-1047
        • Abu-Rustum N.R.
        • Yashar C.M.
        • Bradley K.
        • et al.
        National Comprehensive Cancer Network clinical practice guidelines in oncology: uterine cancer. Version 1.2022.
        (Available at:) (Accessed December 12, 2021)
        • Walker J.L.
        • Piedmonte M.R.
        • Spirtos N.M.
        • et al.
        Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2.
        J Clin Oncol. 2009; 27: 5331-5336
        • Janda M.
        • Gebski V.
        • Davies L.C.
        • et al.
        Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial.
        JAMA. 2017; 317: 1224-1233
        • Cihoric N.
        • Crowe S.
        • Eychmüller S.
        • et al.
        Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy.
        Radiat Oncol. 2012; 7: 132
        • Onsrud M.
        • Hagen B.
        • Strickert T.
        10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri.
        Gynecol Oncol. 2001; 82: 167-171
        • Shuja M.
        • Nazli S.
        • Mansha M.A.
        • et al.
        Bleeding in locally invasive pelvic malignancies: is hypofractionated radiation therapy a safe and effective non-invasive option for securing hemostasis? A single institution perspective.
        Cureus. 2018; 10: e2137
        • Butala A.A.
        • Lee D.Y.
        • Patel R.R.
        • et al.
        A retrospective study of rapid symptom response in bleeding gynecologic malignancies with short course palliative radiation therapy: less is more.
        J Pain Symptom Manage. 2021; 61: 377-383.e372
        • Kim J.J.
        • Chapman-Davis E.
        Role of progesterone in endometrial cancer.
        Semin Reprod Med. 2010; 28: 81-90
        • Gunderson C.C.
        • Fader A.N.
        • Carson K.A.
        • et al.
        Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.
        Gynecol Oncol. 2012; 125: 477-482
        • Abu-Rustum N.R.
        • Yashar C.M.
        • Bradley K.
        • et al.
        National Comprehensive Cancer Network clinical practice guidelines in oncology: cervical cancer. Version 1.2022.
        (Available at:) (Accessed December 12, 2021)
        • Piver M.S.
        • Rutledge F.
        • Smith J.P.
        Five classes of extended hysterectomy for women with cervical cancer.
        Obstet Gynecol. 1974; 44: 265-272
        • Querleu D.
        • Morrow C.P.
        Classification of radical hysterectomy.
        Lancet Oncol. 2008; 9: 297-303
        • Ramirez P.T.
        • Frumovitz M.
        • Pareja R.
        • et al.
        Minimally invasive versus abdominal radical hysterectomy for cervical cancer.
        N Engl J Med. 2018; 379: 1895-1904
        • Sonoo T.
        • Inokuchi R.
        • Yamamoto M.
        • et al.
        Severe hemorrhage from cervical cancer managed with foley catheter balloon tamponade.
        West J Emerg Med. 2015; 16: 793-794
        • Fletcher H.
        • Wharfe G.
        • Mitchell S.
        • et al.
        Treatment of intractable vaginal bleeding with formaldehyde soaked packs.
        J Obstet Gynaecol. 2002; 22: 570-571
        • Yanazume S.
        • Douzono H.
        • Yanazume Y.
        • et al.
        New hemostatic method using Mohs' paste for fatal genital bleeding in advanced cervical cancer.
        Gynecol Oncol Case Rep. 2013; 4: 47-49
        • Attarbashi S.
        • Faulkner R.L.
        • Slade R.J.
        The use of Monsel's solution and vaginal pack for haemostasis in cold knife cone biopsy.
        J Obstet Gynaecol. 2007; 27: 189
        • Duenas-Garcia OF
        • Goldberg J.M.
        Topical hemostatic agents in gynecologic surgery.
        Obstet Gynecol Surv. 2008; 63 ([quiz: 405]): 389-394
        • Vilardo N.
        • Feinberg J.
        • Black J.
        • et al.
        The use of QuikClot combat gauze in cervical and vaginal hemorrhage.
        Gynecol Oncol Rep. 2017; 21: 114-116
        • Arzol Chemical Co
        Arzol silver nitrate applicators (75% silver nitrate/25% potassium nitrate) [prescribing information].
        (Available at:) (Accessed December 26, 2021)
        • Ngan H.Y.S.
        • Seckl M.J.
        • Berkowitz R.S.
        • et al.
        Update on the diagnosis and management of gestational trophoblastic disease.
        Int J Gynaecol Obstet. 2018; 143: 79-85
        • Berkowitz R.S.
        • Goldstein D.P.
        Clinical practice. Molar pregnancy.
        N Engl J Med. 2009; 360: 1639-1645
        • Soper J.T.
        Gestational trophoblastic disease: current evaluation and management.
        Obstet Gynecol. 2021; 137: 355-370
      1. Management of gestational trophoblastic disease: green-top guideline No. 38 - June 2020.
        BJOG. 2021; 128: e1-e27
      2. Gestational trophoblastic disease.
        in: Hoffman B.L. Schorge J.O. Schaffer J.I. Williams gynecology. 2nd edition. McGraw Hill Medical, Chicago (IL)2012: 898-915
        • Berkowitz R.S.
        • Horowitz N.S.
        • Elias K.M.
        Hydatidiform mole: treatment and follow-up.
        (Available at:) (Accessed December 19, 2021)
        • Tse K.Y.
        • Chan K.K.
        • Tam K.F.
        • et al.
        20-year experience of managing profuse bleeding in gestational trophoblastic disease.
        J Reprod Med. 2007; 52: 397-401
        • Sugrue R.
        • Foley O.
        • Elias K.M.
        • et al.
        Outcomes of minimally invasive versus open abdominal hysterectomy in patients with gestational trophoblastic disease.
        Gynecol Oncol. 2021; 160: 445-449
        • Patel M.
        • Stuparich M.
        • Nahas S.
        Total laparoscopic hysterectomy in combination with dilation and evacuation of an 18-week-sized uterus with gestational trophoblastic neoplasia: a novel treatment approach.
        Am J Obstet Gynecol. 2021; 224: 314-315
        • Schink J.C.
        • Lurain J.R.
        Gestational trophoblastic disease: molar pregnancy and gestational trophoblastic neoplasia.
        in: Chi D.S. Berchuck A. Dizon D.S. Principles and practice of gynecologic oncology. 7th edition. Wolters Kluwer, Philadelphia (PA)2017: 744-765
        • Osborne R.J.
        • Filiaci V.L.
        • Schink J.C.
        • et al.
        Second curettage for low-risk nonmetastatic gestational trophoblastic neoplasia.
        Obstet Gynecol. 2016; 128: 535-542
        • Nogueira-García J.
        • Moreno-Selva R.
        • Ruiz-Sánchez M.E.
        • et al.
        [Uterine artery embolization as palliative treatment in cervical cancer].
        Ginecol Obstet Mex. 2015; 83: 289-293
        • Field K.
        • Ryan M.J.
        • Saadeh F.A.
        • et al.
        Selective arterial embolisation for intractable vaginal haemorrhage in genital tract malignancies.
        Eur J Gynaecol Oncol. 2016; 37: 736-740
        • Hague J.
        • Tippett R.
        Endovascular techniques in palliative care.
        Clin Oncol (R Coll Radiol). 2010; 22: 771-780
        • Revel-Mouroz P.
        • Mokrane F.Z.
        • Collot S.
        • et al.
        Hemostastic embolization in oncology.
        Diagn Interv Imaging. 2015; 96: 807-821
        • Alméciga A.
        • Rodriguez J.
        • Beltrán J.
        • et al.
        Emergency embolization of pelvic vessels in patients with locally advanced cervical cancer and massive vaginal bleeding: a case series in a Latin American oncological center.
        JCO Glob Oncol. 2020; 6: 1376-1383
        • Johnstone C.
        • Rich S.E.
        Bleeding in cancer patients and its treatment: a review.
        Ann Palliat Med. 2018; 7: 265-273
        • Wright J.D.
        • Ananth C.V.
        • Lewin S.N.
        • et al.
        Patterns of use of hemostatic agents in patients undergoing major surgery.
        J Surg Res. 2014; 186: 458-466
        • Anderson C.K.
        • Medlin E.
        • Ferriss A.F.
        • et al.
        Association between gelatin-thrombin matrix use and abscesses in women undergoing pelvic surgery.
        Obstet Gynecol. 2014; 124: 589-595
        • Frati A.
        • Thomassin-Naggara I.
        • Bazot M.
        • et al.
        Accuracy of diagnosis on CT scan of Surgicel® Fibrillar: results of a prospective blind reading study.
        Eur J Obstet Gynecol Reprod Biol. 2013; 169: 397-401
        • Stachowicz A.M.
        • Whiteside J.L.
        Topical hemostatic agents in gynecologic surgery for benign indications.
        Obstet Gynecol. 2020; 135: 463-468
        • Zhang J.J.
        • Cao D.Y.
        • Yang J.X.
        • et al.
        Ovarian metastasis from nongynecologic primary sites: a retrospective analysis of 177 cases and 13-year experience.
        J Ovarian Res. 2020; 13: 128
        • Moradi A.
        • Shakiba B.
        • Maghsoudi R.
        • et al.
        Vaginal bleeding as primary presentation of renal cell carcinoma.
        CEN Case Rep. 2020; 9: 138-140
        • Abdalla A.S.
        • Lazarevska A.
        • Omer M.M.
        • et al.
        Metastatic breast cancer to the cervix presenting with abnormal vaginal bleeding during chemotherapy: a case report and literature review.
        Chirurgia (Bucur). 2018; 113: 564-570
        • Nohuz E.
        • Kullab S.
        • Ledoux-Pilon A.
        • et al.
        Vaginal lymphoma: a possible cause of genital hemorrhage.
        Turk J Haematol. 2016; 33: 259-260
        • Kunos C.A.
        • Brindle J.
        • Waggoner S.
        • et al.
        Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies.
        Front Oncol. 2012; 2: 181
        • Beriwal S.
        • Heron D.E.
        • Mogus R.
        • et al.
        High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina.
        Radiat Oncol. 2008; 3: 7
        • Rogers D.M.
        • Crookston K.P.
        The approach to the patient who refuses blood transfusion.
        Transfusion. 2006; 46: 1471-1477
        • Vadhan-Raj S.
        • Strauss W.
        • Ford D.
        • et al.
        Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron.
        Am J Hematol. 2014; 89: 7-12
        • Jo K.I.
        • Shin J.W.
        • Choi T.Y.
        • et al.
        Eight-year experience of bloodless surgery at a tertiary care hospital in Korea.
        Transfusion. 2013; 53: 948-954
      3. Ortho Biotech Products L.P. Procrit (Epoetin alfa) for injection [product labeling].
        (Available at:) (Accessed December 19, 2021)